Total Payments
$77,353
2024 Payments
$4,464
Companies
12
Transactions
100
Medicare Patients
1,920
Medicare Billing
$816,078
Payment Breakdown by Category
Other$69,749 (90.2%)
Food & Beverage$3,387 (4.4%)
Travel$3,384 (4.4%)
Consulting$725.00 (0.9%)
Education$108.51 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,117 | 12 | 45.4% |
| Honoraria | $34,632 | 16 | 44.8% |
| Food and Beverage | $3,387 | 47 | 4.4% |
| Travel and Lodging | $3,384 | 23 | 4.4% |
| Consulting Fee | $725.00 | 1 | 0.9% |
| Education | $108.51 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| La Jolla Pharmaceutical Company | $72,071 | 79 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $3,005 | 9 | $0 (2019) |
| Becton, Dickinson and Company | $1,150 | 2 | $0 (2024) |
| Bard Access Systems, Inc. | $300.00 | 1 | $0 (2017) |
| Abbott Laboratories | $193.65 | 2 | $0 (2017) |
| ABIOMED | $126.25 | 1 | $0 (2019) |
| Alcresta Therapeutics, Inc. | $123.92 | 1 | $0 (2024) |
| ExThera Medical Corporation | $117.72 | 1 | $0 (2023) |
| Intuitive Surgical, Inc. | $111.89 | 1 | $0 (2022) |
| Astute Medical, Inc. | $108.51 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,464 | 7 | La Jolla Pharmaceutical Company ($3,790) |
| 2023 | $7,512 | 7 | La Jolla Pharmaceutical Company ($7,394) |
| 2022 | $10,955 | 10 | La Jolla Pharmaceutical Company ($10,843) |
| 2021 | $1,325 | 2 | La Jolla Pharmaceutical Company ($725.00) |
| 2020 | $6,513 | 11 | La Jolla Pharmaceutical Company ($6,486) |
| 2019 | $14,032 | 24 | La Jolla Pharmaceutical Company ($10,883) |
| 2018 | $32,059 | 36 | La Jolla Pharmaceutical Company ($31,950) |
| 2017 | $493.65 | 3 | Bard Access Systems, Inc. ($300.00) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/24/2024 | Becton, Dickinson and Company | BD BBL Gram Iodine (Stabilized) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Diagnostic Testing | ||||||
| 08/13/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,528.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 08/13/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 06/26/2024 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $123.92 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/21/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/21/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $102.58 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 03/14/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,528.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/28/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,528.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/28/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $119.78 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/28/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $39.48 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/16/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $117.42 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 02/16/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | Cash or cash equivalent | $61.48 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 01/22/2023 | ExThera Medical Corporation | — | Food and Beverage | Cash or cash equivalent | $117.72 | General |
| 11/22/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $111.89 | General |
| Category: SURGERY | ||||||
| 10/27/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,040.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 09/28/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $97.94 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/04/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,040.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/21/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $4,343.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/14/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $63.88 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/14/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $30.21 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 03/23/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $78.39 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 03/23/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $55.56 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 03/09/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $94.41 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 05/11/2021 | Becton, Dickinson and Company | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 469 | 2,396 | $518,571 | $197,155 |
| 2022 | 7 | 436 | 2,218 | $512,114 | $182,279 |
| 2021 | 9 | 502 | 2,367 | $620,721 | $222,084 |
| 2020 | 10 | 513 | 2,284 | $596,294 | $214,561 |
Total Patients
1,920
Total Services
9,265
Medicare Billing
$816,078
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 125 | 872 | $133,189 | $56,409 | 42.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 118 | 256 | $154,646 | $44,371 | 28.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 38 | 678 | $97,637 | $40,742 | 41.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 77 | 390 | $86,600 | $38,016 | 43.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 18 | 70 | $13,300 | $5,884 | 44.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 34 | 34 | $15,039 | $4,572 | 30.4% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 16 | $5,520 | $2,421 | 43.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 19 | 56 | $4,632 | $2,109 | 45.5% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 12 | 12 | $4,263 | $1,346 | 31.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,745 | $1,284 | 34.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 122 | 634 | $143,324 | $53,530 | 37.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 115 | 257 | $153,447 | $45,931 | 29.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 99 | 741 | $112,699 | $43,273 | 38.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 34 | 453 | $65,232 | $25,063 | 38.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 38 | $16,523 | $6,267 | 37.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 13 | 77 | $14,679 | $5,735 | 39.1% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 17 | 18 | $6,210 | $2,480 | 39.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 172 | 447 | $260,887 | $82,815 | 31.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 125 | 652 | $146,322 | $56,544 | 38.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 82 | 641 | $96,944 | $37,930 | 39.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 23 | 413 | $59,472 | $23,661 | 39.8% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 23 | 133 | $25,270 | $10,025 | 39.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 37 | 37 | $16,545 | $6,155 | 37.2% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 17 | 20 | $6,900 | $2,698 | 39.1% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 12 | 12 | $4,369 | $1,410 | 32.3% |
About Dr. David Willms, M.D
Dr. David Willms, M.D is a Pulmonary Disease healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285626747.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Willms, M.D has received a total of $77,353 in payments from pharmaceutical and medical device companies, with $4,464 received in 2024. These payments were reported across 100 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,117).
As a Medicare-enrolled provider, Willms has provided services to 1,920 Medicare beneficiaries, totaling 9,265 services with total Medicare billing of $816,078. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Hospitalist
- Location San Diego, CA
- Active Since 08/19/2005
- Last Updated 11/16/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1285626747
Products in Payments
- GIAPREZA (Drug) $71,862
- ANDEXXA (Biological) $3,005
- BD BBL Gram Iodine (Stabilized) (Device) $550.00
- BAS-Power-TrialysisTM (Device) $300.00
- Impella (Device) $126.25
- RELIZORB (Device) $123.92
- CardioMEMS HF System (Device) $120.49
- Da Vinci Surgical System (Device) $111.89
- Nephrocheck (Device) $108.51
- Circulatory Support (Device) $73.16
- CARDIOHELP (Device) $27.60
- XACDURO (Drug) $21.09
- INVOKANA (Drug) $17.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in San Diego
Dr. George Cheng, Md Phd, MD PHD
Pulmonary Disease — Payments: $230,134
Pulmonary Disease $230,134
Dr. Xuanha White, D.o, D.O
Pulmonary Disease — Payments: $216,172
Pulmonary Disease $216,172
Praveen Akuthota, M.d, M.D
Pulmonary Disease — Payments: $183,353
Pulmonary Disease $183,353
Wael El Maraachli, Md, MD
Pulmonary Disease — Payments: $114,418
Pulmonary Disease $114,418
Dr. Demosthenes Papamatheakis, Md, MD
Pulmonary Disease — Payments: $111,552
Pulmonary Disease $111,552
Dr. Robert Owens, Md, MD
Pulmonary Disease — Payments: $106,126
Pulmonary Disease $106,126